文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

HER2 in brain metastases: issues of concordance, survival, and treatment.

作者信息

Fuchs Ilka B, Loebbecke Maren, Buhler Helmut, Stoltenburg-Didinger Gisela, Heine Bernhard, Lichtenegger Werner, Schaller Gerard

出版信息

J Clin Oncol. 2002 Oct 1;20(19):4130-3. doi: 10.1200/JCO.2002.04.016.

DOI:10.1200/JCO.2002.04.016
PMID:12351617
Abstract
摘要

相似文献

[1]
HER2 in brain metastases: issues of concordance, survival, and treatment.

J Clin Oncol. 2002-10-1

[2]
[Brain metastases in breast cancer: a special disease course for HER2 positive tumors].

Ned Tijdschr Geneeskd. 2008-12-13

[3]
Trastuzumab treatment beyond brain progression in HER2- positive metastatic breast cancer.

Ann Oncol. 2009-1

[4]
Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer.

Oncologist. 2007-12

[5]
Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.

Cancer Chemother Pharmacol. 2009-5

[6]
Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer.

Ann Oncol. 2009-1

[7]
Extended survival in women with brain metastases from HER2 overexpressing breast cancer.

Am J Clin Oncol. 2008-6

[8]
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.

Breast Cancer Res. 2005

[9]
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab.

Acta Oncol. 2006

[10]
Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.

Breast. 2006-4

引用本文的文献

[1]
The tumor-nerve circuit in breast cancer.

Cancer Metastasis Rev. 2023-6

[2]
Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.

Stem Cells. 2015-10

[3]
Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.

Oncologist. 2015-5

[4]
Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.

Neuro Oncol. 2015-9

[5]
CNS metastases in breast cancer patients: prognostic implications of tumor subtype.

Med Oncol. 2015-1

[6]
Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine.

Case Rep Oncol. 2014-8-7

[7]
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases.

Mol Clin Oncol. 2013-11

[8]
Risk factors and survival outcome in cerebral metastatic breast cancer.

Med Oncol. 2014-2-7

[9]
Emerging role of brain metastases in the prognosis of breast cancer patients.

Breast Cancer (Dove Med Press). 2011-8-10

[10]
Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer.

J Cancer Res Clin Oncol. 2013-9-14

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索